Physicians' Academy for Cardiovascular Education

11 Practical implications of REDUCE-IT

10' education - Oct. 28, 2022 - Prof. Subodh Verma, MD, PhD - Toronto, ON, Canada

Video navigation menu

  • 1) REDUCE-IT confirms safety of IPA 0:34
  • 2) Efficacy on top of 'placebo'  2:12
  • 3) Reduction in CV death 3:08
  • 4) Benefit at all levels of LDL-c and TG 3:49
  • 5) Consistent efficacy in high-risk primary and secondary prevention 5:03
  • 6) Efficacy accross all eGFR 5:53
  • 7) Marked reduction in stroke 6:41
  • 8) Broad generalizability 7:43
  • 9) Translational data: atherosclerosis regression 9:19
  • 10) Widespread guideline endorsement 10:44
  • 11) It's not fish oil: Formulation matters 14:06


Show transcript

Educational information

This lecture by Prof. Verma was part of the EBAC-accredited symposium "New frontiers in ASCVD risk reduction: integrating icosapent ethyl in clinical practice" held during the ESC congress 2022.


Prof. Subodh Verma is cardiac surgeon at St. Michael's Hospital and professor at the University of Toronto in Toronto, Ont, Canada.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant from Amarin.

View the slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: